BRAIN+ A/SBRAIN+ A/SBRAIN+ A/S

BRAIN+ A/S

No trades
See on Supercharts

BRAINP fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Brain+ A/S is engaged in the developing of medical software to detect and treat the cognitive symptoms of dementia and the most common cause of dementia, namely Alzheimer's disease. It is involved in digital therapeutics that can be used independently or in combination with traditional medications, devices, and other therapies to optimize patient care and health outcomes. The company was founded by Kim Baden-Kristensen, Ulrik Ditlev Eriksen, and Rasmus Højengaard on April 17, 2012 and is headquartered in Copenhagen, Denmark.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
BRAINP has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company